🔎 Trials Near Me

홈 › 결장암 › 조지아

조지아의 결장암 임상 시험

결장암 관련 연구 15개가 조지아 내 여러 지역에서 참여자를 모집하고 있습니다.

조지아의 도시

공식 연구 텍스트(영어)

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

  • Piedmont Atlanta Hospital ( Site 2002), Atlanta
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06997497

Shield Post-Approval Study Protocol

  • Keith Family Medicine, Conyers
  • Keith Family Medicine, Dawsonville
  • Primeway Clinical Research Group, Fayetteville
  • 외 1개
피험자 모집 중관찰 연구건강한 지원자 환영
45세 ~ 81세 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06880055

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

  • Phoebe Putney Memorial Hospital, Albany
  • University Cancer and Blood Center LLC, Athens
  • Northside Hospital, Atlanta
  • 외 6개
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05174169

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

  • Northside Hospital, Atlanta
  • Tift Regional Medical Center, Tifton
피험자 모집 중건강한 지원자 환영
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07283939

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

  • Augusta University Medical Center, Augusta
  • Low Country Cancer Care, Savannah
  • Memorial Health University Medical Center, Savannah
피험자 모집 중
45세 ~ 70세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05080673

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

  • Total Health Center, Decatur
  • Piedmont Cancer Institute, Locust Grove
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT07284849

Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3

  • City of Hope Atlanta Cancer Center, Newnan
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT07595874

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  • University Cancer & Blood Center, LLC, Athens
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 8. 업데이트됨 · NCT07222800

Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer

  • Emory Decatur Hospital, Atlanta
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • 외 2개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT07140679

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

  • Emory Winship Cancer Institute, Atlanta
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 26. 업데이트됨 · NCT07321106

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

  • Xencor Investigative Site, Atlanta
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT05433142

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • University Cancer and Blood Center, Athens
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 5. 27. 업데이트됨 · NCT03093116

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

  • Piedmont Healthcare, Atlanta
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 5. 15. 업데이트됨 · NCT05379985

Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment

  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital, Atlanta
  • Emory Saint Joseph's Hospital, Atlanta
  • 외 1개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 4. 17. 업데이트됨 · NCT07405476

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Atlanta
  • Massive Bio SYNERGY-AI site, Savannah
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.